Dr. Steven Zanganeh’s research goals are directed toward developing immunoengineering systems for high-dimensional analysis of tumor microenvironment, immuno-imaging, and uncovering the overlooked factors in sex-specific variations in nano-immunotherapy. Dr. Zanganeh is planning to link the fields of nanomedicine, immunotherapy, and molecular imaging towards more efficient and accurate diagnosis, personalized therapies and ultimately improving treatment outcomes and patient quality of life. Two major questions in Zangeneh’s research are, “What role do nanoparticles play in the tumor microenvironment (TME) to regulate innate and adaptive immune systems?” And, “How and to what extent could cell sex alter the regulation of innate and adaptive immune systems in TME upon treatment with NPs?”